CytoSorbents Analyst Ratings
CytoSorbents Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | 51.93% | HC Wainwright & Co. | → $5.5 | Reiterates | Buy → Buy |
| 05/03/2023 | 51.93% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
| 03/10/2023 | 51.93% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
| 11/04/2022 | 51.93% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
| 05/04/2022 | 65.75% | B. Riley Securities | $7 → $6 | Maintains | Buy |
| 05/04/2022 | 148.62% | HC Wainwright & Co. | $13 → $9 | Maintains | Buy |
| 09/17/2020 | 314.36% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 09/01/2020 | 314.36% | SVB Leerink | → $15 | Initiates Coverage On | → Outperform |
| 05/06/2020 | 341.99% | B. Riley Securities | $12 → $16 | Maintains | Buy |
| 05/06/2020 | 286.74% | HC Wainwright & Co. | $13 → $14 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/02/2023 | 51.93% | HC Wainwright & Co. | → 5.5 美元 | 重申 | 购买 → 购买 |
| 05/03/2023 | 51.93% | HC Wainwright & Co. | → 5.5 美元 | 重申 | → 购买 |
| 03/10/2023 | 51.93% | HC Wainwright & Co. | → 5.5 美元 | 重申 | → 购买 |
| 2022 年 4 月 11 日 | 51.93% | HC Wainwright & Co. | 9 美元 → 5.5 美元 | 维护 | 购买 |
| 05/04/2022 | 65.75% | B. 莱利证券 | 7 美元 → 6 美元 | 维护 | 购买 |
| 05/04/2022 | 148.62% | HC Wainwright & Co. | 13 美元 → 9 美元 | 维护 | 购买 |
| 09/17/2020 | 314.36% | 杰富瑞 | → 15 美元 | 启动覆盖开启 | → 购买 |
| 2020 年 1 月 9 日 | 314.36% | SVB Leerink | → 15 美元 | 启动覆盖开启 | → 跑赢大盘 |
| 2020 年 6 月 5 日 | 341.99% | B. 莱利证券 | 12 美元 → 16 美元 | 维护 | 购买 |
| 2020 年 6 月 5 日 | 286.74% | HC Wainwright & Co. | 13 美元 → 14 美元 | 维护 | 购买 |
What is the target price for CytoSorbents (CTSO)?
CytoSorbents (CTSO) 的目标价格是多少？
The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by HC Wainwright & Co. on August 2, 2023. The analyst firm set a price target for $5.50 expecting CTSO to rise to within 12 months (a possible 51.93% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月2日公布了CytoSorbents（纳斯达克股票代码：CTSO）的最新目标股价。这家分析公司将目标股价定为5.50美元，预计CTSO将在12个月内升至51.93％（可能上涨51.93％）。去年有4家分析公司公布了评级。
What is the most recent analyst rating for CytoSorbents (CTSO)?
分析师对CytoSorbents（CTSO）的最新评级是多少？
The latest analyst rating for CytoSorbents (NASDAQ: CTSO) was provided by HC Wainwright & Co., and CytoSorbents reiterated their buy rating.
CytoSorbents（纳斯达克股票代码：CTSO）的最新分析师评级由HC Wainwright & Co. 提供，CytoSorbents重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for CytoSorbents (CTSO)?
CytoSorbents（CTSO）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
分析师在进行了广泛的研究（包括浏览公开财务报表、与CytoSorbents的高管和客户交谈以及听取财报电话会议）后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。CytoSorbents的最后一次评级是在2023年8月2日提交的，因此你应该预计下一个评级将在2024年8月2日左右公布。
Is the Analyst Rating CytoSorbents (CTSO) correct?
分析师对 CytoSorbents (CTSO) 的评级是否正确？
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a reiterated with a price target of $0.00 to $5.50. The current price CytoSorbents (CTSO) is trading at is $3.62, which is within the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的CytoSorbents（CTSO）评级得到了重申，目标股价为0.00美元至5.50美元。CytoSorbents（CTSO）目前的交易价格为3.62美元，在分析师的预测区间内。